|YTD NAV Return||+29.79|
|YTD Market Return||+30.18|
|Shares Outstanding||6.21 Mil|
- Last trade 5/17/2013 3:59 PM ET
|The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the Dynamic Biotechnology & Genome IntellidexSM Index. The fund generally will invest at least 90% of its total assets in common stocks of biotechnology companies and genome companies that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of 30 U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.|
- * Annualized returns
- Data through 4/29/2013 8:00 PM ET
- Invesco PowerShares Expands Fundamental Fixed-Income Line With Emerging Market Local Currency Sovereign Debt PortfolioMarketwire | 5/9/2013
- Marketwire | 5/8/2013
- Seeking Alpha | 4/11/2013
|Category||Specialty - Health|
|Morningstar Risk||Above Average|
|Morningstar Return||Below Average|
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Quotes delayed 15min, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.